ATI RN
ATI Community Health Proctored Exam 2019
1. When writing a community diagnosis, the community health nurse notes that the 'among' phrase:
- A. Presents a synthesis of all assessment data.
- B. Provides the supporting data.
- C. Specifies the aggregate that will benefit from the nurse's plan.
- D. Describes the cause of the health problem and directs focus of interventions.
Correct answer: C
Rationale: In community diagnosis, the 'among' phrase is used to specify the particular population group that will benefit from the nurse's plan. It helps in targeting interventions and tailoring healthcare activities to the identified group within the community.
2. One way to determine staffing needs is to classify clients according to nursing care required. Another name for this is a(n) __________.
- A. self-scheduling
- B. supplementing staff system
- C. patient classification system (PCS)
- D. acuity system
Correct answer: D
Rationale: The correct answer is D: acuity system. An acuity system involves classifying clients based on the nursing care they require to determine staffing needs accurately. Choice A, self-scheduling, is not related to classifying clients based on care needs. Choice B, supplementing staff system, does not specifically refer to the classification of clients. Choice C, patient classification system (PCS), is close but not as commonly used as 'acuity system' in healthcare settings to determine staffing needs.
3. A nurse is reviewing the laboratory results of a client who is receiving warfarin therapy for atrial fibrillation. Which of the following laboratory values should the nurse report to the provider?
- A. INR 1.8
- B. Hemoglobin 14 g/dL
- C. Platelets 175,000/mm³
- D. Potassium 3.8 mEq/L
Correct answer: A
Rationale: The correct answer is A. An INR of 1.8 is below the therapeutic range for a client receiving warfarin, indicating a potential risk of blood clots. This value should be reported to the provider for further evaluation and possible adjustment of the warfarin dosage. Choices B, C, and D are within normal ranges and do not directly relate to the effectiveness or safety of warfarin therapy in this scenario, making them less urgent to report.
4. Which of the following women is at highest risk for the development of endometrial cancer?
- A. A 50-year-old postmenopausal woman with a history of high-risk human papillomavirus
- B. A 45-year-old woman who is obese and has a menstrual pattern consisting of periods of amenorrhea and infrequent periods
- C. A 40-year-old woman who is overweight and has hypertension
- D. A 55-year-old woman who smokes
Correct answer: A 45-year-old woman who is obese and has a menstrual pattern consisting of periods of amenorrhea and infrequent periods
Rationale: The correct answer is a 45-year-old woman who is obese and has a menstrual pattern consisting of periods of amenorrhea and infrequent periods. Obesity and prolonged exposure to estrogen unopposed by progesterone due to infrequent ovulation are significant risk factors for endometrial cancer. Choices A, C, and D do not directly correlate with the increased risk of endometrial cancer. Postmenopausal status alone (Choice A), overweight with hypertension (Choice C), and smoking (Choice D) are not the primary risk factors for endometrial cancer.
5. A client has a new prescription for Spironolactone. Which of the following instructions should be provided?
- A. Take the medication with food.
- B. Avoid potassium-rich foods.
- C. Increase your intake of sodium.
- D. Monitor your blood pressure daily.
Correct answer: B
Rationale: The correct answer is to 'Avoid potassium-rich foods.' Spironolactone is a potassium-sparing diuretic, and consuming foods high in potassium can lead to hyperkalemia, a potential side effect of the medication. Therefore, the client should be advised to avoid potassium-rich foods to prevent complications. Choices A, C, and D are incorrect. Taking Spironolactone with food is not necessary for its effectiveness. Increasing sodium intake is not typically recommended with Spironolactone therapy. While monitoring blood pressure is important, it is not specifically related to the use of Spironolactone.
Similar Questions
Access More Features
ATI Basic
- 50,000 Questions with answers
- All ATI courses Coverage
- 30 days access @ $69.99
ATI Basic
- 50,000 Questions with answers
- All ATI courses Coverage
- 90 days access @ $149.99